{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.117.1.7.1.232","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.117.1.7.1.232/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.232","version":"eCQM Update 2020-05-07","name":"Warfarin","title":"Warfarin","status":"active","date":"2017-07-26","description":"(Clinical Focus: This value set contains concepts that represent warfarin medications that are administered to patients to reduce the risk of blood clot formation.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are prescribed warfarin therapy at discharge following acute myocardial infarction.),(Inclusion Criteria: Includes only relevant concepts associated with drug forms that are consistent with oral administration, such as tablets. Only single ingredient.),(Exclusion Criteria: No exclusions.)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2020-01","concept":[{"code":"855288","display":"Warfarin Sodium 1 MG Oral Tablet"},{"code":"855296","display":"Warfarin Sodium 10 MG Oral Tablet"},{"code":"855302","display":"Warfarin Sodium 2 MG Oral Tablet"},{"code":"855312","display":"Warfarin Sodium 2.5 MG Oral Tablet"},{"code":"855318","display":"Warfarin Sodium 3 MG Oral Tablet"},{"code":"855324","display":"Warfarin Sodium 4 MG Oral Tablet"},{"code":"855332","display":"Warfarin Sodium 5 MG Oral Tablet"},{"code":"855338","display":"Warfarin Sodium 6 MG Oral Tablet"},{"code":"855344","display":"Warfarin Sodium 7.5 MG Oral Tablet"}]}]}}